HeartMate^® II continuous-flow left ventricular assist system

References

• Lloyd-Jones D, Adams R, Carnethon M et al.Heart disease and stroke statistics – 2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation119, 480–486 (2009).
   PubMed Web of Science ®Google Scholar
• Fang J, Mensah GA, Croft JB, Keenan NL. Heart failure-related hospitalization in the U.S., 1979 to 2004. J. Am. Coll. Cardiol.52, 428–434 (2008).
   PubMed Web of Science ®Google Scholar
• Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur. J. Heart. Fail.12, 434–443 (2010).
   PubMed Web of Science ®Google Scholar
• Jessup M, Brozena S. Heart failure. N. Engl. J. Med.348, 2007–2018 (2003).
   PubMed Web of Science ®Google Scholar
• Taylor DO, Stehlik J, Edwards LB et al.Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult heart transplant report-2009. J. Heart Lung Transplant.28, 1007–1022 (2009).
   PubMed Web of Science ®Google Scholar
• Hershberger RE, Nauman D, Walker TL, Dutton D, Burgess D. Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure. J. Card. Fail.9, 180–187 (2003).
   PubMed Web of Science ®Google Scholar
• Rogers JG, Butler J, Lansman SL et al.Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J. Am. Coll. Cardiol.50, 741–747 (2007).
   PubMed Web of Science ®Google Scholar
• Gorodeski EZ, Chu EC, Reese JR, Shishehbor MH, Hsich E, Starling RC. Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure. Circ. Heart Fail.2, 320–324 (2009).
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Naftel DC, Kormos RL et al.Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants. J. Heart Lung Transplant.29, 1–10 (2010).
   PubMed Web of Science ®Google Scholar
• Kirklin J, Frazier O. Developmental History of Mechanical Circulatory Support. In: Mechanical Circulatory Support. Elsevier, London, UK (2006).
   Google Scholar
• DeBakey ME. Left ventricular bypass pump for cardiac assistance. Clinical experience. Am. J. Cardiol.27, 3–11 (1971).
   PubMed Web of Science ®Google Scholar
• Akutsu T, Mirkovitch V, Topaz SR, Kolff WJ. Silastic sac type of artifical heart and its use in calves. Trans. Am. Soc. Artif. Intern. Organs9, 281–285 (1963).
   Google Scholar
• Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD. Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am. J. Cardiol.24, 723–730 (1969).
   PubMed Web of Science ®Google Scholar
• DeVries WC. The permanent artificial heart. Four case reports. JAMA259, 849–859 (1988).
   PubMed Web of Science ®Google Scholar
• DeVries WC, Anderson JL, Joyce LD et al.Clinical use of the total artificial heart. N. Engl. J. Med.310, 273–278 (1984).
   PubMed Web of Science ®Google Scholar
• Copeland JG, Smith R, Icenogle T et al.Orthotopic total artificial heart bridge to transplantation: preliminary results. J. Heart Transplant.8, 124–137 (1989).
   Google Scholar
• McCarthy PM, Portner PM, Tobler HG, Starnes VA, Ramasamy N, Oyer PE. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application. J. Thorac. Cardiovasc. Surg.102, 578–586 (1991).
   PubMed Web of Science ®Google Scholar
• Hill JD, Farrar DJ, Hershon JJ et al.Use of a prosthetic ventricle as a bridge to cardiac transplantation for postinfarction cardiogenic shock. N. Engl. J. Med.314, 626–628 (1986).
   Google Scholar
• Boilson BA, Raichlin E, Park SJ, Kushwaha SS. Device therapy and cardiac transplantation for end-stage heart failure. Curr. Probl. Cardiol.35, 8–64 (2010).
   Google Scholar
• Rose EA, Gelijns AC, Moskowitz AJ et al.Long-term mechanical left ventricular assistance for end-stage heart failure. N. Engl. J. Med.345, 1435–1443 (2001).
   PubMed Web of Science ®Google Scholar
• Goldstein D, Zucker M, Pagani FD, Frazier OH. Rotary Ventricular Assist Devices. In: Mechanical Circulatory Support. Kirklin JK FO (Ed.). ISHLT Monograph Series, Elsevier, London, UK, 84–92 (2006).
   Google Scholar
• Slaughter MS, Pagani FD, Rogers JG et al.Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J. Heart Lung Transplant.29, S1–S39 (2010).
   Google Scholar
• Birks EJ. Left ventricular assist devices. Heart96, 63–71 (2010).
   PubMed Web of Science ®Google Scholar
• Baughman KL, Jarcho JA. Bridge to life – cardiac mechanical support. N. Engl. J. Med.357, 846–849 (2007).
   PubMed Web of Science ®Google Scholar
• Heartmate® II LVAS: Instructions For Use. Thoratec Corporation, Pleasanton, CA, USA (2008).
   Google Scholar
• Miller LW, Pagani FD, Russell SD et al.Use of a continuous-flow device in patients awaiting heart transplantation. N. Engl. J. Med.357, 885–896 (2007).
   PubMed Web of Science ®Google Scholar
• Pagani FD, Miller LW, Russell SD et al.Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J. Am. Coll. Cardiol.54, 312–321 (2009).
   PubMed Web of Science ®Google Scholar
• Slaughter MS, Rogers JG, Milano CA et al.Advanced heart failure treated with continuous-flow left ventricular assist device. N. Engl. J. Med.361, 2241–2251 (2009).
   PubMed Web of Science ®Google Scholar
• Rogers JG, Aaronson KD, Boyle AJ et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J. Am. Coll. Cardiol.55, 1826–1834 (2010).
   PubMed Web of Science ®Google Scholar
• Kormos RL, Teuteberg JJ, Pagani FD et al.Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J. Thorac. Cardiovasc. Surg.139(5), 1316–1324 (2010).
   PubMed Web of Science ®Google Scholar
• Boyle AJ, Russell SD, Teuteberg JJ et al.Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. J. Heart Lung Transplant.28, 881–887 (2009).
   PubMed Web of Science ®Google Scholar
• Kamdar F, Boyle A, Liao K et al.Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J. Heart Lung Transplant.28, 352–359 (2009).
   PubMed Web of Science ®Google Scholar
• Russell SD, Rogers JG, Milano CA et al.Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation120, 2352–2357 (2009).
   PubMed Web of Science ®Google Scholar
• Crow S, John R, Boyle A et al.Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. J. Thorac. Cardiovasc. Surg.137, 208–215 (2009).
   PubMed Web of Science ®Google Scholar
• Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J. Am. Coll. Cardiol.53, 2162–2167 (2009).
   PubMed Web of Science ®Google Scholar
• Geisen U, Heilmann C, Beyersdorf F et al.Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. Eur. J. Cardiothorac. Surg.33, 679–684 (2008).
   PubMed Web of Science ®Google Scholar
• Mudd JO, Cuda JD, Halushka M et al.Fusion of aortic valve commissures in patients supported by a continuous axial flow left ventricular assist device. J. Heart Lung Transplant.27, 1269–1274 (2008).
   PubMed Web of Science ®Google Scholar
• Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J. Heart Lung Transplant.26, 815–818 (2007).
   PubMed Web of Science ®Google Scholar
• den Uil CA, Maat AP, Lagrand WK et al.Mechanical circulatory support devices improve tissue perfusion in patients with end-stage heart failure or cardiogenic shock. J. Heart Lung Transplant.28, 906–911 (2009).
   Google Scholar